A61K 9/2009
Inorganic compounds
Official title: {Inorganic compounds}
A61K9/2009 (Inorganic compounds) appears on 1,987 US grants and 3,893 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,987
- Published applications
- 3,893
- Assignees
- 1,352
- Inventors
- 6,494
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 1 | 0 |
| 1978 | 3 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 3 | 0 |
| 1982 | 3 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 8 | 0 |
| 1986 | 5 | 0 |
| 1987 | 10 | 0 |
| 1988 | 6 | 0 |
| 1989 | 10 | 0 |
| 1990 | 7 | 0 |
| 1991 | 11 | 0 |
| 1992 | 8 | 0 |
| 1993 | 7 | 0 |
| 1994 | 10 | 0 |
| 1995 | 12 | 0 |
| 1996 | 13 | 0 |
| 1997 | 20 | 0 |
| 1998 | 21 | 0 |
| 1999 | 26 | 0 |
| 2000 | 29 | 0 |
| 2001 | 36 | 8 |
| 2002 | 28 | 49 |
| 2003 | 41 | 97 |
| 2004 | 31 | 80 |
| 2005 | 20 | 114 |
| 2006 | 13 | 97 |
| 2007 | 18 | 101 |
| 2008 | 24 | 91 |
| 2009 | 14 | 106 |
| 2010 | 19 | 106 |
| 2011 | 34 | 101 |
| 2012 | 45 | 95 |
| 2013 | 69 | 145 |
| 2014 | 81 | 158 |
| 2015 | 100 | 206 |
| 2016 | 90 | 216 |
| 2017 | 109 | 203 |
| 2018 | 96 | 168 |
| 2019 | 114 | 200 |
| 2020 | 115 | 218 |
| 2021 | 117 | 205 |
| 2022 | 112 | 243 |
| 2023 | 103 | 225 |
| 2024 | 132 | 245 |
| 2025 | 121 | 230 |
| 2026 | 87 | 186 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Dosage forms for TYK2 inhibitors6 Oct 2026US 12,751,948 B2Bristol-Myers Squibb Company
- Anticancer compositions29 Sep 2026US 12,746,230 B2Aragon Pharmaceuticals, Inc.
- Solid pharmaceutical preparation, preparation method therefor and use thereof29 Sep 2026US 12,746,241 B2Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- Treatment of agitation associated with Alzheimer's disease with a combination of bupropion and dextromethorphan22 Sep 2026US 12,740,949 B2Antecip Bioventures II LLC
- Pharmaceutical composition of pitolisant hydrochloride and their process for the preparation22 Sep 2026US 12,740,972 B2Msn Laboratories Private Limited, R&D Center
- Pharmaceutical oral dosage form of q2038 Oct 2026US 2026/0306411 A1Qurient Co., Ltd.
- Triptolide formulations8 Oct 2026US 2026/0306412 A1Minneamrita Therapeutics LLC
- Colonic purgative tablet and colonic purgative comprising same8 Oct 2026US 2026/0306413 A1Pharmbio Korea Co., Ltd.
- Compounds and combinations thereof for treating neurological and psychiatric conditions8 Oct 2026US 2026/0306426 A1Antecip Bioventures II LLC
- Method and pharmaceutical composition for treating a sleep disorder8 Oct 2026US 2026/0306442 A1Overseas Pharmaceuticals, Ltd.
Most cited
By later US patents
- Method of moving a delivery member of a dispensing device for administration of oral transmucosal dosage forms654US 8,499,966 B2AcelRx Pharmaceuticals, Inc. · 2013
- Oral transmucosal drug dosage using solid solution371US 6,264,981 B1Anesta Corporation · 2001
- Controlled release hydrocodone formulations336US 6,733,783 B2Euro-Celtique S. A. · 2004
- Biodegradable porous ceramic delivery system for bone morphogenetic protein320US 4,596,574 AThe Regents of the University of California · 1986
- Pharmaceutical preparation for oral use320US 4,786,505 AAktiebolaget Hassle · 1988